BofA analyst John Murphy raised the firm’s price target on Tesla (TSLA) to $400 from $350 and keeps a Buy rating on the shares. After having visited Tesla’s Texas gigafactory for a meeting ...
BofA analyst Michael Ryskin raised the firm’s price target on West Pharmaceutical (WST) to $355 from $350 and keeps a Buy rating on the shares. The Life Sciences Tools sector underperformed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback